Speciality Medicines SME
smeOngoing
GMP
₹0
smeOngoing
Speciality Medicines SME
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹0
Investment Timeline
✓
IPO Open
20 Mar 2026
🔒
IPO Close
24 Mar 2026
🎲
Allotment
25 Mar 2026
🔔
Listing
30 Mar 2026
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
STRONG AVOID
34.5/100
🎯 Application Strategy
Action: 🚫 STRONG AVOID - Multiple red flags identified
Lots: DO NOT APPLY
⏳ Timing Advice
📊 Monitor subscription trends before applying
Key Factor Analysis
🚀
Demand
❌ Poor subscription levels - very weak investor interest
💰
Valuation
⚠️ Moderate valuation - fairly priced but limited upside
📈
Listing
❌ Risk of listing at discount or minimal gains
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹117.0 - ₹124.0
📦Lot Size
1000 shares
💰Issue Size
₹29.14 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Speciality Medicines SME?
As of today, the Grey Market Premium (GMP) for Speciality Medicines SME is ₹0, which is approximately null of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Speciality Medicines SME?
Our AI algorithm currently rates this IPO as "STRONG AVOID" with a score of 34.5/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Speciality Medicines SME be announced?
The allotment status for Speciality Medicines SME is expected to be finalized on 25 Mar 2026. Investors can check their status on the registrar's website.
What is the listing date for Speciality Medicines SME?
Shares of Speciality Medicines SME are proposed to be listed on stock exchanges on 30 Mar 2026.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.